Low Dose Antipsychotics in People with Dementia (NICE ADA)

[A version of this item appears in: Dementia and Elderly Care: the Latest Evidence Newsletter (RWHT), Volume 3 Issue 3, October 2012].

Summary

NICE has produced a series of academic detailing aids (ADAs) from “NPC Key Therapeutic Topics: medicines management options for local implementation”. These ADAs are intended to support discussions about key prescribing and medicines optimisation. Academic detailing is thought to improve clinical decision-making, reduce inappropriate prescribing and minimise unnecessary expenditure on healthcare (Soumerai and Avorn (1990), National Audit Office (2007)).

One of these ADAs covers low dose antipsychotics in people with dementia.

Note: This resource is not a NICE guideline and does not supersede or replace any NICE guidance.

Full Text Link

Reference

NICE (2012). Support for education and learning: academic detailing aid. Low dose antipsychotics in people with dementia. London: National Institute for Health and Clinical Excellence (NICE), March / September 2012.

About Dementia and Elderly Care News

Dementia and Elderly Care News. Wolverhampton Medical Institute: WMI. (jh)
This entry was posted in Acute Hospitals, Antipsychotics, Community Care, For Doctors (mostly), For Researchers (mostly), Management of Condition, National, NICE Guidelines, Pharmacological Treatments, Quick Insights and tagged , , , , , , , , , , , , , , . Bookmark the permalink.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out /  Change )

Google photo

You are commenting using your Google account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.